Clinical trial

Serelaxin To Lower Portal Pressure

NCT02669875

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-10-18

PhasePHASE2

Study timeline

Study start (actual)2017-10-18Date precision: day

Registry last updated2018-10-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Liver Cirrhosisunresolved

Hypertension, Portalunresolved

Interventions

SerelaxinDRUG

PlaceboDRUG

Sponsors & collaborators

University of Edinburghlead sponsor

Novartis Pharmaceuticalscollaborator

NHS Lothiancollaborator

Mapped research locations

EdinburghUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02669875 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.